NRX Pharmaceuticals, Inc. Share Price
NRXPNRX Pharmaceuticals, Inc. Stock Performance
Open $2.36 | Prev. Close $2.37 | Circuit Range N/A |
Day Range $2.36 - $2.44 | Year Range $1.58 - $6.01 | Volume 18,054 |
Average Traded $2.39 |
NRX Pharmaceuticals, Inc. Share Price Chart
About NRX Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
NRX Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Jan-26 | $2.36 | $2.38 | +0.00% |
06-Jan-26 | $2.36 | $2.38 | -1.04% |
05-Jan-26 | $2.58 | $2.40 | -8.21% |
02-Jan-26 | $2.68 | $2.62 | -2.60% |
31-Dec-25 | $2.69 | $2.69 | +2.67% |
30-Dec-25 | $2.60 | $2.62 | +0.96% |
29-Dec-25 | $2.63 | $2.60 | +1.57% |